SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001571049-15-004031
Filing Date
2015-05-12
Accepted
2015-05-12 17:16:11
Documents
11
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q t1501103_10q.htm 10-Q 525169
2 EXHIBIT 31.1 t1501103_ex31-1.htm EX-31.1 9413
3 EXHIBIT 31.2 t1501103_ex31-2.htm EX-31.2 9552
4 EXHIBIT 32.1 t1501103_ex32-1.htm EX-32.1 3491
5 EXHIBIT 32.2 t1501103_ex32-2.htm EX-32.2 3784
  Complete submission text file 0001571049-15-004031.txt   3924809

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE cycc-20150331.xml EX-101.INS 457342
7 XBRL SCHEMA FILE cycc-20150331.xsd EX-101.SCH 36862
8 XBRL CALCULATION FILE cycc-20150331_cal.xml EX-101.CAL 38483
9 XBRL DEFINITION FILE cycc-20150331_def.xml EX-101.DEF 121174
10 XBRL LABEL FILE cycc-20150331_lab.xml EX-101.LAB 337281
11 XBRL PRESENTATION FILE cycc-20150331_pre.xml EX-101.PRE 227906
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

IRS No.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50626 | Film No.: 15855453
SIC: 2834 Pharmaceutical Preparations